Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Diseases

  Free Subscription


Articles published in Gut

Retrieve available abstracts of 78 articles:
HTML format
Text format



Single Articles


    April 2017
  1. PARES A
    Juan Rodes. A successful and extraordinary life of a visionary hepatologist.
    Gut. 2017;66:736.
    PubMed     Text format    


    March 2017
  2. HAGSTROM H, Tynelius P, Rasmussen F
    High BMI in late adolescence predicts future severe liver disease and hepatocellular carcinoma: a national, population-based cohort study in 1.2 million men.
    Gut. 2017 Mar 20. pii: gutjnl-2016-313622. doi: 10.1136/gutjnl-2016-313622.
    PubMed     Text format     Abstract available


    February 2017
  3. PARES A
    Juan Rodes. A successful and extraordinary life of a visionary hepatologist.
    Gut. 2017 Feb 24. pii: gutjnl-2017-313950. doi: 10.1136/gutjnl-2017-313950.
    PubMed     Text format    


  4. VAN RENNE N, Roca Suarez AA, Duong FH, Gondeau C, et al
    miR-135a-5p-mediated downregulation of protein tyrosine phosphatase receptor delta is a candidate driver of HCV-associated hepatocarcinogenesis.
    Gut. 2017 Feb 3. pii: gutjnl-2016-312270. doi: 10.1136/gutjnl-2016-312270.
    PubMed     Text format     Abstract available


  5. BRUNT EM, Kleiner DE
    Challenges in the hepatic histopathology in non-alcoholic fatty liver disease.
    Gut. 2017 Feb 3. pii: gutjnl-2016-313379. doi: 10.1136/gutjnl-2016-313379.
    PubMed     Text format    


    January 2017
  6. ALVAREZ-SOLA G, Uriarte I, Latasa MU, Fernandez-Barrena MG, et al
    Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regeneration.
    Gut. 2017 Jan 24. pii: gutjnl-2016-312975. doi: 10.1136/gutjnl-2016-312975.
    PubMed     Text format     Abstract available


  7. MENARD A, Aherfi S, Mokhtari S, Dhiver C, et al
    Toward chronic hepatitis C eradication in HIV-positive patients, including those cirrhotic and infected with genotype 3 viruses.
    Gut. 2017 Jan 10. pii: gutjnl-2016-313431. doi: 10.1136/gutjnl-2016-313431.
    PubMed     Text format    


  8. IKENAGA N, Peng ZW, Vaid KA, Liu SB, et al
    Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal.
    Gut. 2017 Jan 10. pii: gutjnl-2016-312473. doi: 10.1136/gutjnl-2016-312473.
    PubMed     Text format     Abstract available


  9. MAHLI A, Saugspier M, Koch A, Sommer J, et al
    ERK activation and autophagy impairment are central mediators of irinotecan-induced steatohepatitis.
    Gut. 2017 Jan 4. pii: gutjnl-2016-312485. doi: 10.1136/gutjnl-2016-312485.
    PubMed     Text format     Abstract available


    December 2016
  10. FERNANDEZ-BARRENA MG, Perugorria MJ, Banales JM
    Novel lncRNA T-UCR as a potential downstream driver of the Wnt/beta-catenin pathway in hepatobiliary carcinogenesis.
    Gut. 2016 Dec 16. pii: gutjnl-2016-312899. doi: 10.1136/gutjnl-2016-312899.
    PubMed     Text format    


    November 2016
  11. YU J, Yu XL, Han ZY, Cheng ZG, et al
    Percutaneous cooled-probe microwave versus radiofrequency ablation in early-stage hepatocellular carcinoma: a phase III randomised controlled trial.
    Gut. 2016 Nov 24. pii: gutjnl-2016-312629. doi: 10.1136/gutjnl-2016-312629.
    PubMed     Text format    


  12. BOLLARD J, Miguela V, Ruiz de Galarreta M, Venkatesh A, et al
    Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma.
    Gut. 2016 Nov 14. pii: gutjnl-2016-312268. doi: 10.1136/gutjnl-2016-312268.
    PubMed     Text format     Abstract available


    September 2016
  13. KUTTKAT N, Mohs A, Ohl K, Hooiveld G, et al
    Hepatic overexpression of cAMP-responsive element modulator alpha induces a regulatory T-cell response in a murine model of chronic liver disease.
    Gut. 2016 Sep 29. pii: gutjnl-2015-311119. doi: 10.1136/gutjnl-2015-311119.
    PubMed     Text format     Abstract available


  14. DAHEIM M, Lang S, Goeser T, Steffen HM, et al
    Real-world risk score for hepatocellular carcinoma risk prediction in CHBV: a validation outside of Asia.
    Gut. 2016 Sep 26. pii: gutjnl-2016-312993. doi: 10.1136/gutjnl-2016-312993.
    PubMed     Text format    


  15. CAROTENUTO P, Fassan M, Pandolfo R, Lampis A, et al
    Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers.
    Gut. 2016 Sep 12. pii: gutjnl-2016-312278. doi: 10.1136/gutjnl-2016-312278.
    PubMed     Text format     Abstract available


    August 2016
  16. HE GW, Gunther C, Kremer AE, Thonn V, et al
    PGAM5-mediated programmed necrosis of hepatocytes drives acute liver injury.
    Gut. 2016 Aug 26. pii: gutjnl-2015-311247. doi: 10.1136/gutjnl-2015-311247.
    PubMed     Text format     Abstract available



  17. Erratum: Acute kidney injury and acute-on-chronic liver failure classifications in prognosis assessment of patients with acute decompensation of cirrhosis.
    Gut. 2016;65:1394.
    PubMed     Text format    


    July 2016
  18. HACKSTEIN CP, Assmus LM, Welz M, Klein S, et al
    Gut microbial translocation corrupts myeloid cell function to control bacterial infection during liver cirrhosis.
    Gut. 2016 Jul 18. pii: gutjnl-2015-311224. doi: 10.1136/gutjnl-2015-311224.
    PubMed     Text format     Abstract available


    June 2016
  19. MALLAT A, Lotersztajn S
    Targeting cannabinoid receptors in hepatocellular carcinoma?
    Gut. 2016 Jun 24. pii: gutjnl-2016-312108. doi: 10.1136/gutjnl-2016-312108.
    PubMed     Text format    


  20. BHARDWAJ A, Kedarisetty CK, Vashishtha C, Bhadoria AS, et al
    Carvedilol delays the progression of small oesophageal varices in patients with cirrhosis: a randomised placebo-controlled trial.
    Gut. 2016 Jun 13. pii: gutjnl-2016-311735. doi: 10.1136/gutjnl-2016-311735.
    PubMed     Text format     Abstract available


    May 2016
  21. CALO N, Ramadori P, Sobolewski C, Romero Y, et al
    Stress-activated miR-21/miR-21* in hepatocytes promotes lipid and glucose metabolic disorders associated with high-fat diet consumption.
    Gut. 2016 May 24. pii: gutjnl-2015-310822. doi: 10.1136/gutjnl-2015-310822.
    PubMed     Text format     Abstract available


  22. NJEI B, McCarty TR, Garcia-Tsao G
    Beta-blockers in patients with cirrhosis and ascites: type of beta-blocker matters.
    Gut. 2016 May 20. pii: gutjnl-2016-312129. doi: 10.1136/gutjnl-2016-312129.
    PubMed     Text format    


  23. BENOIT B, Pous C
    MAPping the Wnt pathway to hepatocellular carcinoma recurrence.
    Gut. 2016 May 17. pii: gutjnl-2016-311637. doi: 10.1136/gutjnl-2016-311637.
    PubMed     Text format    


  24. SUK KT, Mederacke I, Gwak GY, Cho SW, et al
    Opposite roles of cannabinoid receptors 1 and 2 in hepatocarcinogenesis.
    Gut. 2016 May 11. pii: gutjnl-2015-310212. doi: 10.1136/gutjnl-2015-310212.
    PubMed     Text format     Abstract available


  25. DUPARC T, Plovier H, Marrachelli VG, Van Hul M, et al
    Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism.
    Gut. 2016 May 5. pii: gutjnl-2015-310904. doi: 10.1136/gutjnl-2015-310904.
    PubMed     Text format     Abstract available


  26. GENTLE L, Patanwala I
    Hepatology at a Glance.
    Gut. 2016 May 4. pii: gutjnl-2016-312068. doi: 10.1136/gutjnl-2016-312068.
    PubMed     Text format    


  27. LLOPIS M, Cassard AM, Wrzosek L, Boschat L, et al
    Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease.
    Gut. 2016;65:830-9.
    PubMed     Text format     Abstract available


    April 2016
  28. O'BRIEN A, China L
    Is human albumin solution really the best resuscitation fluid for patients with advanced cirrhosis?
    Gut. 2016 Apr 27. pii: gutjnl-2016-311999. doi: 10.1136/gutjnl-2016-311999.
    PubMed     Text format    


  29. JANSEN C, Bogs C, Krag A, Francque S, et al
    Sequential shear-wave elastography of liver and spleen rules out clinically significant portal hypertension in compensated advanced chronic liver disease.
    Gut. 2016 Apr 27. pii: gutjnl-2016-311955. doi: 10.1136/gutjnl-2016-311955.
    PubMed     Text format    


  30. KITSON MT, Pham A, Gordon A, Kemp W, et al
    High-dose vitamin D supplementation and liver histology in NASH.
    Gut. 2016;65:717-8.
    PubMed     Text format    


  31. MICHELOTTI GA, Tucker A, Swiderska-Syn M, Machado MV, et al
    Pleiotrophin regulates the ductular reaction by controlling the migration of cells in liver progenitor niches.
    Gut. 2016;65:683-92.
    PubMed     Text format     Abstract available


    March 2016
  32. PICCININ E, Moschetta A
    Hepatic-specific PPARalpha-FGF21 action in NAFLD.
    Gut. 2016 Mar 18. pii: gutjnl-2016-311408. doi: 10.1136/gutjnl-2016-311408.
    PubMed     Text format    


  33. BRITO-AZEVEDO A, Perez RM, Coelho HS, Fernandes ES, et al
    Propranolol improves endothelial dysfunction in advanced cirrhosis: the 'endothelial exhaustion' hypothesis.
    Gut. 2016 Mar 16. pii: gutjnl-2016-311696. doi: 10.1136/gutjnl-2016-311696.
    PubMed     Text format    


  34. GARCIA-PRAS E, Gallego J, Coch L, Mejias M, et al
    Role and therapeutic potential of vascular stem/progenitor cells in pathological neovascularisation during chronic portal hypertension.
    Gut. 2016 Mar 16. pii: gutjnl-2015-311157. doi: 10.1136/gutjnl-2015-311157.
    PubMed     Text format     Abstract available


  35. CHEN J, Rajasekaran M, Xia H, Zhang X, et al
    The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/beta-catenin signalling pathway.
    Gut. 2016 Mar 3. pii: gutjnl-2015-310625. doi: 10.1136/gutjnl-2015-310625.
    PubMed     Text format     Abstract available


  36. KALAMBOKIS GN, Baltayiannis G, Christou L, Christodoulou D, et al
    Red signs and not severity of cirrhosis should determine non-selective beta-blocker treatment in Child-Pugh C cirrhosis with small varices: increased risk of hepatorenal syndrome and death beyond 6 months of propranolol use.
    Gut. 2016 Mar 2. pii: gutjnl-2016-311527. doi: 10.1136/gutjnl-2016-311527.
    PubMed     Text format    


  37. ICHOU L, Carbonell N, Rautou PE, Laurans L, et al
    Ascitic fluid TREM-1 for the diagnosis of spontaneous bacterial peritonitis.
    Gut. 2016;65:536-8.
    PubMed     Text format    


    February 2016
  38. JANSEN C, Bogs C, Verlinden W, Thiele M, et al
    Algorithm to rule out clinically significant portal hypertension combining Shear-wave elastography of liver and spleen: a prospective multicentre study.
    Gut. 2016 Feb 19. pii: gutjnl-2016-311536. doi: 10.1136/gutjnl-2016-311536.
    PubMed     Text format    


  39. SHI D, Zhang J, Zhou Q, Xin J, et al
    Quantitative evaluation of human bone mesenchymal stem cells rescuing fulminant hepatic failure in pigs.
    Gut. 2016 Feb 16. pii: gutjnl-2015-311146. doi: 10.1136/gutjnl-2015-311146.
    PubMed     Text format     Abstract available


  40. YANG Y, Lin X, Lu X, Luo G, et al
    Interferon-microRNA signalling drives liver precancerous lesion formation and hepatocarcinogenesis.
    Gut. 2016 Feb 9. pii: gutjnl-2015-310318. doi: 10.1136/gutjnl-2015-310318.
    PubMed     Text format     Abstract available


  41. WIESER V, Adolph TE, Enrich B, Kuliopulos A, et al
    Reversal of murine alcoholic steatohepatitis by pepducin-based functional blockade of interleukin-8 receptors.
    Gut. 2016 Feb 8. pii: gutjnl-2015-310344. doi: 10.1136/gutjnl-2015-310344.
    PubMed     Text format     Abstract available


  42. MARCHESI JR, Adams DH, Fava F, Hermes GD, et al
    The gut microbiota and host health: a new clinical frontier.
    Gut. 2016;65:330-9.
    PubMed     Text format     Abstract available


    January 2016
  43. POH Z, Shen L, Yang HI, Seto WK, et al
    Real-world risk score for hepatocellular carcinoma (RWS-HCC): a clinically practical risk predictor for HCC in chronic hepatitis B.
    Gut. 2016 Jan 19. pii: gutjnl-2015-310818. doi: 10.1136/gutjnl-2015-310818.
    PubMed     Text format    


  44. TILG H, Mathurin P
    Altered intestinal microbiota as a major driving force in alcoholic steatohepatitis.
    Gut. 2016 Jan 19. pii: gutjnl-2015-311014. doi: 10.1136/gutjnl-2015-311014.
    PubMed     Text format    


  45. STOCKDALE AJ, Phillips RO, Geretti AM
    The gamma-glutamyl transpeptidase to platelet ratio (GPR) shows poor correlation with transient elastography measurements of liver fibrosis in HIV-positive patients with chronic hepatitis B in West Africa. Response to: 'The gamma-glutamyl transpeptida
    Gut. 2016 Jan 4. pii: gutjnl-2015-311133. doi: 10.1136/gutjnl-2015-311133.
    PubMed     Text format    


    December 2015
  46. GARNELO M, Tan A, Her Z, Yeong J, et al
    Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma.
    Gut. 2015 Dec 15. pii: gutjnl-2015-310814. doi: 10.1136/gutjnl-2015-310814.
    PubMed     Text format     Abstract available


  47. TOVAR V, Cornella H, Moeini A, Vidal S, et al
    Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma.
    Gut. 2015 Dec 11. pii: gutjnl-2015-309501. doi: 10.1136/gutjnl-2015-309501.
    PubMed     Text format     Abstract available


  48. HU HH, Liu J, Lin YL, Luo WS, et al
    The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B.
    Gut. 2015 Dec 7. pii: gutjnl-2015-310686. doi: 10.1136/gutjnl-2015-310686.
    PubMed     Text format     Abstract available


    October 2015
  49. NAHON P, Lescat M, Layese R, Bourcier V, et al
    Bacterial infection in compensated viral cirrhosis impairs 5-year survival (ANRS CO12 CirVir prospective cohort).
    Gut. 2015 Oct 28. pii: gutjnl-2015-310275. doi: 10.1136/gutjnl-2015-310275.
    PubMed     Text format     Abstract available


  50. LI X, Yao W, Yuan Y, Chen P, et al
    Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
    Gut. 2015 Oct 9. pii: gutjnl-2015-310514. doi: 10.1136/gutjnl-2015-310514.
    PubMed     Text format     Abstract available


  51. FLECKEN T, Sarobe P
    Tim-3 expression in tumour-associated macrophages: a new player in HCC progression.
    Gut. 2015;64:1502-3.
    PubMed     Text format    


  52. YAN W, Liu X, Ma H, Zhang H, et al
    Tim-3 fosters HCC development by enhancing TGF-beta-mediated alternative activation of macrophages.
    Gut. 2015;64:1593-604.
    PubMed     Text format     Abstract available


    September 2015
  53. KLEIN S, Rick J, Lehmann J, Schierwagen R, et al
    Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis.
    Gut. 2015 Sep 17. pii: gutjnl-2015-309600. doi: 10.1136/gutjnl-2015-309600.
    PubMed     Text format     Abstract available


  54. BEUERS U, Gershwin ME, Gish RG, Invernizzi P, et al
    Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis'.
    Gut. 2015 Sep 14. pii: gutjnl-2015-310593. doi: 10.1136/gutjnl-2015-310593.
    PubMed     Text format    


  55. LOYER X, Paradis V, Henique C, Vion AC, et al
    Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARalpha expression.
    Gut. 2015 Sep 3. pii: gutjnl-2014-308883. doi: 10.1136/gutjnl-2014-308883.
    PubMed     Text format     Abstract available


  56. CAUCHY F, Mebarki M, Albuquerque M, Laouirem S, et al
    Anti-angiogenic effect of metformin in human liver carcinogenesis related to metabolic syndrome.
    Gut. 2015;64:1498-500.
    PubMed     Text format    


    August 2015
  57. YU J, Li X, Tao Q, Yu XL, et al
    Hypermethylation of ZNF545 is associated with poor prognosis in patients with early-stage hepatocellular carcinoma after thermal ablation.
    Gut. 2015 Aug 19. pii: gutjnl-2015-310258. doi: 10.1136/gutjnl-2015-310258.
    PubMed     Text format    


  58. WU H, Ng R, Chen X, Steer CJ, et al
    MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway.
    Gut. 2015 Aug 17. pii: gutjnl-2014-308430. doi: 10.1136/gutjnl-2014-308430.
    PubMed     Text format     Abstract available


  59. LU XJ, Dong J, Ji LJ, Luo JH, et al
    Safety and efficacy of TACE and gamma knife on hepatocellular carcinoma with portal vein invasion.
    Gut. 2015 Aug 12. pii: gutjnl-2015-310292. doi: 10.1136/gutjnl-2015-310292.
    PubMed     Text format    


    July 2015
  60. COOMBES JD, Swiderska-Syn M, Dolle L, Reid D, et al
    Osteopontin neutralisation abrogates the liver progenitor cell response and fibrogenesis in mice.
    Gut. 2015;64:1120-31.
    PubMed     Text format     Abstract available


    June 2015
  61. LEMOINE M, Shimakawa Y, Nayagam S, Khalil M, et al
    The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa.
    Gut. 2015 Jun 24. pii: gutjnl-2015-309260. doi: 10.1136/gutjnl-2015-309260.
    PubMed     Text format     Abstract available


  62. WILHELM A, Aldridge V, Haldar D, Naylor AJ, et al
    CD248/endosialin critically regulates hepatic stellate cell proliferation during chronic liver injury via a PDGF-regulated mechanism.
    Gut. 2015 Jun 15. pii: gutjnl-2014-308325. doi: 10.1136/gutjnl-2014-308325.
    PubMed     Text format     Abstract available


  63. ZHANG DY, Goossens N, Guo J, Tsai MC, et al
    A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resection.
    Gut. 2015 Jun 4. pii: gutjnl-2015-309655. doi: 10.1136/gutjnl-2015-309655.
    PubMed     Text format     Abstract available


  64. BENESIC A, Leitl A, Gerbes AL
    Monocyte-derived hepatocyte-like cells for causality assessment of idiosyncratic drug-induced liver injury.
    Gut. 2015 Jun 4. pii: gutjnl-2015-309528. doi: 10.1136/gutjnl-2015-309528.
    PubMed     Text format     Abstract available


  65. BEDRELI S, Sowa JP, Gerken G, Saner FH, et al
    Management of acute-on-chronic liver failure: rotational thromboelastometry may reduce substitution of coagulation factors in liver cirrhosis.
    Gut. 2015 Jun 3. pii: gutjnl-2015-309922. doi: 10.1136/gutjnl-2015-309922.
    PubMed     Text format    


  66. QI X, Li Z, Huang J, Zhu Y, et al
    Virtual portal pressure gradient from anatomic CT angiography.
    Gut. 2015;64:1004-5.
    PubMed     Text format    


    May 2015
  67. TAKUMA Y, Nouso K, Morimoto Y, Tomokuni J, et al
    Prediction of oesophageal variceal bleeding by measuring spleen stiffness in patients with liver cirrhosis.
    Gut. 2015 May 25. pii: gutjnl-2015-309741. doi: 10.1136/gutjnl-2015-309741.
    PubMed     Text format    


  68. ENGSTLER AJ, Aumiller T, Degen C, Durr M, et al
    Insulin resistance alters hepatic ethanol metabolism: studies in mice and children with non-alcoholic fatty liver disease.
    Gut. 2015 May 25. pii: gutjnl-2014-308379. doi: 10.1136/gutjnl-2014-308379.
    PubMed     Text format     Abstract available


  69. HAN CY, Lim SW, Koo JH, Kim W, et al
    PHLDA3 overexpression in hepatocytes by endoplasmic reticulum stress via IRE1-Xbp1s pathway expedites liver injury.
    Gut. 2015 May 12. pii: gutjnl-2014-308506. doi: 10.1136/gutjnl-2014-308506.
    PubMed     Text format     Abstract available


  70. NOBILI V, Reif S
    Vitamin D and liver fibrosis: let's start soon before it's too late.
    Gut. 2015;64:698-9.
    PubMed     Text format    


  71. LEE YA, Wallace MC, Friedman SL
    Pathobiology of liver fibrosis: a translational success story.
    Gut. 2015;64:830-41.
    PubMed     Text format     Abstract available


  72. GRETEN TF, Wang XW, Korangy F
    Current concepts of immune based treatments for patients with HCC: from basic science to novel treatment approaches.
    Gut. 2015;64:842-8.
    PubMed     Text format     Abstract available


  73. PIROLA CJ, Fernandez Gianotti T, Castano GO, Mallardi P, et al
    Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis.
    Gut. 2015;64:800-12.
    PubMed     Text format     Abstract available


    April 2015
  74. PLOMPEN EP, Hansen BE, Schouten JN, Darwish Murad S, et al
    Interferon gamma receptor 2 gene variants are associated with liver fibrosis in the general population: the Rotterdam Study.
    Gut. 2015;64:692-4.
    PubMed     Text format    


  75. JANSSEN MJ, Salomon J, Cnossen WR, Bergmann C, et al
    Somatic loss of polycystic disease genes contributes to the formation of isolated and polycystic liver cysts.
    Gut. 2015;64:688-90.
    PubMed     Text format    


    February 2015
  76. ARABZADEH A, Dupaul-Chicoine J, Breton V, Haftchenary S, et al
    Carcinoembryonic Antigen Cell Adhesion Molecule 1 long isoform modulates malignancy of poorly differentiated colon cancer cells.
    Gut. 2015 Feb 9. pii: gutjnl-2014-308781. doi: 10.1136/gutjnl-2014-308781.
    PubMed     Text format     Abstract available


    December 2014
  77. JOOSSE ME, Schipper ME, Libbrecht L, Buuren HR, et al
    Recurrent cholangitis in a 65-year-old man.
    Gut. 2014 Dec 22. pii: gutjnl-2014-308726. doi: 10.1136/gutjnl-2014-308726.
    PubMed     Text format    


    October 2014
  78. LEITHEAD JA, Rajoriya N, Tehami N, Hodson J, et al
    Non-selective beta-blockers are associated with improved survival in patients with ascites listed for liver transplantation.
    Gut. 2014 Oct 3. pii: gutjnl-2013-306502. doi: 10.1136/gutjnl-2013-306502.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: